Ambarish Shah

Person

Gaithersburg, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions comprising coformulation of anti-PD-L1 and anti-CTLA-4...
- Patent number 10,421,811
- Issue date Sep 24, 2019
- MedImmune, LLC
- Jiali Du
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for purifying active polypeptides or immunoconjugates
- Patent number 10,072,083
- Issue date Sep 11, 2018
- MedImmune, LLC
- Thomas Linke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for purifying active polypeptides or immunoconjugates
- Patent number 9,580,461
- Issue date Feb 28, 2017
- MedImmune, LLC
- Thomas Linke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein formulation
- Patent number 9,308,257
- Issue date Apr 12, 2016
- MedImmune, LLC
- Monika S. Sharma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY FORMULATION
- Publication number 20200216541
- Publication date Jul 9, 2020
- Medimmune, LLC
- Hasige Sathish
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS COMPRISING COFORMULATION OF ANTI-PD-L1 AND ANTI-CTLA-4...
- Publication number 20190382494
- Publication date Dec 19, 2019
- Medimmune, LLC
- Jiali DU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR PURIFYING ACTIVE POLYPEPTIDES OR IMMUNOCONJUGATES
- Publication number 20180371094
- Publication date Dec 27, 2018
- Medimmune, LLC
- Thomas LINKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LIQUID ANTIBODY FORMULATION WITH IMPROVED AGGREGATION PROPERTIES
- Publication number 20180243415
- Publication date Aug 30, 2018
- MEDIMMUNE LIMITED
- Priyanka MALLIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS COMPRISING COFORMULATION OF ANTI-PD-L1 AND ANTI-CTLA-4...
- Publication number 20170306025
- Publication date Oct 26, 2017
- Medimmune, LLC
- Jiali DU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY FORMULATION
- Publication number 20170174766
- Publication date Jun 22, 2017
- Medimmune, LLC
- Hasige Sathish
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR PURIFYING ACTIVE POLYPEPTIDES OR IMMUNOCONJUGATES
- Publication number 20170145100
- Publication date May 25, 2017
- Medimmune, LLC
- Thomas LINKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEIN FORMULATION
- Publication number 20160215051
- Publication date Jul 28, 2016
- Medimmune, LLC
- Monika S. SHARMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Liquid Antibody Formulation With Improved Aggregation Properties
- Publication number 20150344557
- Publication date Dec 3, 2015
- Medlmmune, LLC
- Priyanka Malik
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR PURIFYING ACTIVE POLYPEPTIDES OR IMMUNOCONJUGATES
- Publication number 20130202626
- Publication date Aug 8, 2013
- Medimmune, LLC
- Thomas Linke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-CD 19 ANTIBODY FORMULATIONS
- Publication number 20120148576
- Publication date Jun 14, 2012
- Medlmmune, LLC
- Monika S. Sharma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY FORMULATION
- Publication number 20110293605
- Publication date Dec 1, 2011
- Hasige Sathish
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Protein Formulation
- Publication number 20100303827
- Publication date Dec 2, 2010
- One Medimmune Way
- Monika S. Sharma, SR.
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Ambarish Shah

Person

Patents Grantslast 30 patents

Compositions comprising coformulation of anti-PD-L1 and anti-CTLA-4...

Method for purifying active polypeptides or immunoconjugates

Method for purifying active polypeptides or immunoconjugates

Protein formulation

Patents Applicationslast 30 patents

ANTIBODY FORMULATION

COMPOSITIONS COMPRISING COFORMULATION OF ANTI-PD-L1 AND ANTI-CTLA-4...

METHOD FOR PURIFYING ACTIVE POLYPEPTIDES OR IMMUNOCONJUGATES

LIQUID ANTIBODY FORMULATION WITH IMPROVED AGGREGATION PROPERTIES

COMPOSITIONS COMPRISING COFORMULATION OF ANTI-PD-L1 AND ANTI-CTLA-4...

ANTIBODY FORMULATION

METHOD FOR PURIFYING ACTIVE POLYPEPTIDES OR IMMUNOCONJUGATES

PROTEIN FORMULATION

Liquid Antibody Formulation With Improved Aggregation Properties

METHOD FOR PURIFYING ACTIVE POLYPEPTIDES OR IMMUNOCONJUGATES

HUMANIZED ANTI-CD 19 ANTIBODY FORMULATIONS

ANTIBODY FORMULATION

Protein Formulation